News
Sustainable Packaging: The Secret to Cutting Costs in the Pharmaceutical Industry
Discover how sustainable packaging practices can help you reduce environmental impact and significantly cut costs.
Read on to uncover the connection between sustainability and profitability in switching to sustainable pharmaceutical packaging solutions starting today.
Understanding the Cost Implications of Traditional Packaging
Traditional...
News
Aptar Pharma Continues Global Expansion Program with ?Opening of New Mumbai Site
Aptar Pharma, a global leader in drug delivery systems, services and active material science solutions, today announced the opening of its new Aptar Mumbai site, which will increase manufacturing capabilities in South East Asia.
An inauguration ceremony held on December...
News
Recipharm announces collaboration with Oz-UK to accelerate the development of low global warming potential pMDIs utilising HFA-152a propellant
Global contract development and manufacturing organisation (CDMO), Recipharm has announced a collaboration with Oz-UK, a Contract Research Organisation (CRO) and provider of solutions for respiratory R&D, to accelerate the development and manufacture of “green” pressurised metered dose inhalers (pMDIs)....
News
The New Pharma Legislation – A Long-Term Robust Approach
It is worth noting that political decision-makers at present happen to be under pressure to swiftly accomplish the initial reading of the European Union's ambitious new pharmaceutical legislation before the upcoming European elections in May 2024. It is extremely...
Drug Research
RSSL announces new state-of-the-art facility opening as part of ambitious expansion plan
RSSL, a cutting-edge food and pharmaceutical contract research organisation announced the opening of its new state-of-the-art analytical testing facility on the University of Reading Whiteknights campus, as part of an ambitious expansion plan. The new facility will increase capacity...
Drug Research
Novo Nordisk invests more than 16 billion Danish kroner in expansion of production facilities in Chartres, France
Novo Nordisk announced the investment of more than 16 billion Danish kroner (2.1 billion euros) starting in 20231 to expand the existing production site in Chartres, France, for the current and future product portfolio within serious chronic diseases.
The investment...
Drug Research
BMS, Avidity add another $100M to cardiovascular partnership
Avidity Biosciences, Inc., a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), today announced a global licensing and research collaboration with Bristol Myers Squibb focused on the discovery, development and commercialization...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read